•
Jun 30, 2023

iTeos Therapeutics Q2 2023 Earnings Report

EPS
-$0.96
Previous year: $0.15
-740.0%
Cash and Equivalents
$216M
Previous year: $792M
-72.7%
Free Cash Flow
-$30.2M
Previous year: -$30.8M
-1.9%
Total Assets
$704M
Previous year: $815M
-13.6%

iTeos Therapeutics

iTeos Therapeutics